Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Tabersonine" patented technology

Tabersonine is a terpene indole alkaloid found in the medicinal plant Catharanthus roseus. Tabersonine is hydroxylated at the 16 position by the enzyme tabersonine 16-hydroxylase (T16H) to form 16-hydroxytabersonine. The enzyme leading to its formation is currently unknown. Tabersonine is the first intermediate leading to the formation of vindoline one of the two precursors required for vinblastine biosynthesis.

Clean technology for extracting tabersonine from Voacanga chalotiana Pierre ex Stapf

The invention relates to the plant extraction field, and aims to provide an efficient and environmentally-friendly technology for extracting tabersonine from Voacanga chalotiana Pierre ex Stapf. The technology comprises the following steps: 1, taking Voacanga chalotiana Pierre ex Stapf, sun-drying, peeling shells, and crushing; 2, micronizing treatment: adding submicron powder obtained in step 1 into ethyl acetate having a volume 1.5-3 times the mass of the submicron powder, and carrying out ultrasonic treatment at normal temperature for 0.5-1h, and centrifuging; 3, carrying out reflux extraction of the filter residue obtained in step 2 for 0.5-2h twice by utilizing ethyl acetate having a volume 2-5 times the mass of the filter residue; 4, mixing the obtained reflux extract liquid with the obtained centrifugate obtained after the ultrasonic treatment, and concentrating until no droplets drop; 5, adding an aqueous solution containing 6-10% of TritonX-114 having a volume 0.5-3 times the volume of the concentrate obtained in step 4, carrying out heat insulation stirring at 35-50DEG C for 0.5-1h, and centrifuging; and 6, adding a proper amount of water to the solid obtained in step 5, stirring for 10-20min, allowing the obtained solution to stand for separating out the upper layer yellow oil, and extracting 1-3 times by using the above same method, wherein the yellow oil is liquid tabersonine. The technology has the advantages of ingenious combination, high total extraction efficiency and less pollution emission.
Owner:重庆恒芯紫来科技有限公司

Preparation process of alkaloid tabersonine

InactiveCN102250092AThe amount of extraction solvent is reducedReduce lossesOrganic chemistryVoacangaSolvent
The invention relates to a preparation process of alkaloid tabersonine, relating to the technical field of biopharmaceuticals. The traditional biological preparation process of the tabersonine has the problems of large solvent loss amount, high cost, large water consumption, high adsorbent resin price, and the like. The preparation process of the alkaloid tabersonine, disclosed by the invention, comprises the following steps of: squeezing voacanga seeds; carrying out solvent extraction; carrying out acid water extraction and washing; and carrying out acid water purification, alkalinization and extraction. According to the preparation process disclosed by the invention, solvent dimethylbenzene which has high boiling point, low cost and easiness in obtaining is adopted as an extractant, anda mode of the acid water extraction and washing is adopted, and therefore, the using amount and the treatment capacity of acid water are reduced; extracted diluted acid water is treated by adopting the dimethylbenzene, and therefore the adsorption washing or repeated salt transformation purification process of the conventional macroporous resin is saved; the content of the tabersonine reaches more than 98 percent, and the extraction ratio is between 1.8 percent and 2.0 percent; in addition, according to the invention, production cost is reduced, and water consumption and solvent consumption are reduced.
Owner:ZHANGJIAKOU GERUI HIGH TECH

Preparation method of high-purity vinpocetine

The invention discloses a preparation method of high-purity vinpocetine. The preparation method comprises the following steps: S1, preparing vincamine, wherein tabersonine is dissolved, a hydrogenation reaction is performed under the catalysis of palladium and carbon to obtain vincadifformine, the vincadifformine is oxidized to obtain a vincadifformine nitric oxide, and an intermediate vincamine is obtained from the vincadifformine nitric oxide reaction liquid under the catalysis of an acid; S2, dewatering the vincamine by using toluene as a solvent and adding a dewatering agent to obtain apovincamine; and S3, on the basis of the step S2, carrying out a transesterification reaction by taking ethanol as a solvent, using dichloromethane as a cosolvent and using sodium ethoxide / sodium methoxide as a catalyst to obtain a vinpocetine crude product, and re-crystallizing with ethanol to obtain vinpocetine. The process provided by the invention has the advantages of simple production operation, avoidance of high-toxicity reagents, less impurity of the obtained product, high production efficiency, simple and convent operation and environmental friendliness, wherein the purity of the productis more than 99.9%, the quality of the product is higher than the quality of the product obtained by the original research factory, and the medicinal requirements are met.
Owner:GUANGZHOU YIPINHONG PHARMA +4

Process for preparing vincamine by semisynthetic method

The invention relates to a synthetic process for chemical medicines, in particular to a process for preparing vincamine by a semisynthetic method. At present, the process for preparing the vincamine is divided into a total synthetic method and the semisynthetic method, wherein the semisynthetic method has the problems of unstable and inflammable hydrogenation catalyst, large using amount, high hydrogenation pressure, insecurity in the preparation of monoperoxide maleic acid and the like. The process comprises the following steps of: preparing tabersonine vincadifformine hydrochloride, preparing the monoperoxide maleic acid, performing oxidizing reaction, performing reduction reaction and transposition reaction, precipitating ammonia and purifying products, wherein the low-cost and stable Pd / C hydrogenation catalyst is selected to reduce the pressure of the hydrogenation reaction; tabersonine sulfate is replaced by the tabersonine hydrochloride; the monoperoxide maleic acid is preparedby using low-concentration hydrogen peroxide; the reaction temperature is below 0 DEG C, and security coefficients are improved; the temperature of the oxidizing reaction is reduced, and the generation of isomers is reduced; purification and solvent recrystallization are performed by column chromatography; and the quality of the products reaches the pharmaceutical-grade standard.
Owner:ZHANGJIAKOU GERUI HIGH TECH

Technology for quickly detecting tabersonine in voacanga seeds

The invention discloses a technological method for detecting tabersonine in voacanga seeds. The technological method includes (1) sampling and crushing; uniformly sampling from various points, uniformly mixing voacanga seed samples and crushing the voacanga seed samples for standby application; (2) extracting: adding 3g of the crushed voacanga seed samples into an extracting tank, further adding 25ml of methanol in the extracting tank, extracting by the aid of ultrasonic waves for 30 minutes, allowing the mixture to stand for 30 minutes and cooling the mixture to reach the room temperature; and (3) detecting liquid phases: taking from 1ml to 10ml of supernate obtained in the step (2) into a measuring flask, metering the supernate to a certain graduation, using the supernate as to-be-tested liquid, respectively precisely metering 5 microliters of comparison liquid with the concentration of 1mg / ml and 5 microliters of the to-be-tested liquid and filling the comparison liquid and the to-be-tested liquid into a liquid chromatograph, and recording the peak area and obtaining the content of the to-be-tested liquid according to a content computational formula. The technological method has the advantages that consumption of raw materials is low, required time is short, accuracy of detection results is high, and relative errors are fewer.
Owner:重庆恒芯紫来科技有限公司

Clean technology for extracting tabersonine from Voacanga chalotiana Pierre ex Stapf

The invention relates to the plant extraction field, and aims to provide an efficient and environmentally-friendly technology for extracting tabersonine from Voacanga chalotiana Pierre ex Stapf. The technology comprises the following steps: 1, taking Voacanga chalotiana Pierre ex Stapf, sun-drying, peeling shells, and crushing; 2, micronizing treatment: adding submicron powder obtained in step 1 into ethyl acetate having a volume 1.5-3 times the mass of the submicron powder, and carrying out ultrasonic treatment at normal temperature for 0.5-1h, and centrifuging; 3, carrying out reflux extraction of the filter residue obtained in step 2 for 0.5-2h twice by utilizing ethyl acetate having a volume 2-5 times the mass of the filter residue; 4, mixing the obtained reflux extract liquid with the obtained centrifugate obtained after the ultrasonic treatment, and concentrating until no droplets drop; 5, adding an aqueous solution containing 6-10% of TritonX-114 having a volume 0.5-3 times the volume of the concentrate obtained in step 4, carrying out heat insulation stirring at 35-50DEG C for 0.5-1h, and centrifuging; and 6, adding a proper amount of water to the solid obtained in step 5, stirring for 10-20min, allowing the obtained solution to stand for separating out the upper layer yellow oil, and extracting 1-3 times by using the above same method, wherein the yellow oil is liquid tabersonine. The technology has the advantages of ingenious combination, high total extraction efficiency and less pollution emission.
Owner:重庆恒芯紫来科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products